| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485111 | Tuberculosis | 2018 | 4 Pages |
Abstract
The present study calls attention for the potential use of INH/RIF/LVX and INH/RIF/LNZ combinations in the treatment of resistant TB.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Nathally Claudiane de Souza Santos, Regiane Bertin de Lima Scodro, Aryadne Larissa de Almeida, Vanessa Pietrowski Baldin, Sandra Sayuri Nakamura de Vasconcelos, Vera Lucia Dias Siqueira, Katiany Rizzieri Caleffi-Ferracioli,